As we observed that Dvl2 can reduce the release of IL-1β, IL-6, and IL-8 in vivo, we next evaluated whether this effect is the result of significant apoptosis of RA-FLSs or a direct effect of Dvl2. This evidence concerns the gene DVL2 and rheumatoid arthritis.